Patient reported voice handicap and auditory-perceptual voice assessment outcomes in patients with COVID-19

Tahir, Emel; Kavaz, Esra; Kurnaz, Senem Çengel; Temoçin, Fatih; Atilla, Aynur

doi:10.1080/14015439.2021.2011958

Cited by 14 publications

(16 citation statements)

References 25 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Moreover, another reason for the findings of this study can be the fact that patients were assessed during the acute phase of COVID-19 infection who were hospitalized in the ward. Our results were in line with former studies done by Saki et al and Tahir et al regarding CAPE-V p results in assessing the voice of COVID-19 patients 24 , 30 . In another study by Tohidast et al (2020), the voice quality of COVID patients was evaluated by the GRBAS scale and the impact of Covid-19 on these aspects of the patient's voice was also declared to be statistically significant 28 that was parallel with our study.…”

Section: Discussionsupporting

confidence: 94%

“…Based on the given reasons, it is evidently demonstrated in the severity score, for it shows the severity and grade of dysphonia in these patients. Moreover, due to the insufficient air pressure and insufficient respiratory capacity caused by COVID-19, and alteration in vocal folds’ vibrating pattern and closure 12 , 30 , 57 , patients vocalize with more strain, roughness, and breathiness; and also their voice loudness and pitch deteriorate 30 . Moreover, another reason for the findings of this study can be the fact that patients were assessed during the acute phase of COVID-19 infection who were hospitalized in the ward.…”

Section: Discussionmentioning

confidence: 99%

“…The previous studies revealed a significant difference between various aspects of voice quality in COVID-19 patients and healthy people 10 , 12 , 24 , 30 . All of them have shown that the disease could damage various dimensions of voice after recovering from the COVID-19 infection 10 , 32 , 45 , 46 , 47 , but few studies were conducted during the bedridden period of these patients in the hospital 24 , 28 , 29 .…”

Section: Introductionmentioning

confidence: 94%

“…The mentioned factors are evaluated with the diagnostic assessments such as interview, medical examination, self-evaluation, auditory perceptual assessments, aerodynamic-acoustic, and vocal folds’ functional evaluation 27 . In studies related to COVID-19 the voice of the patients assessed with different voice evaluations; such as auditory-perceptual assessments (CAPE-V 2 and GRBAS 3 ) 24 , 28 , 29 , self-report voice questionnaires such as VTD 4 and VHI-10 5 28 , 30 , aerodynamic assessments(S/Z ratio and MPT 6 ) 31 , and acoustic voice analyses like shimmer, HNR, H1H2, CPP, and jitter(12, 32). The use of complimentary voice assessments, e.g., auditory-perceptual and acoustic-aerodynamic measurements, improves the quality of clinical information and allows for a more comprehensive treatment plan 33 , 34 .…”

Section: Introductionmentioning

confidence: 99%

See 3 more Smart Citations

Dysphonia Severity Index and Consensus Auditory-Perceptual Evaluation of Voice Outcomes, and Their Relation in Hospitalized Patients with COVID-19

Aghadoost¹,

Molazeinal²,

Khoddami³

et al. 2022

Journal of Voice

View full text Add to dashboard Cite

Section: Discussionsupporting

confidence: 94%

Section: Discussionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 94%

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Dysphonia Severity Index and Consensus Auditory-Perceptual Evaluation of Voice Outcomes, and Their Relation in Hospitalized Patients with COVID-19

Aghadoost¹,

Molazeinal²,

Khoddami³

et al. 2022

Journal of Voice

View full text Add to dashboard Cite

“…COVID-19 is a severe disease caused by the SARS-CoV-2 virus, which since its first reported cases from Wuhan, Hubei Province, China at the end of 2019 has spread rapidly worldwide [ 1 , 2 , 3 ]. The disease may be asymptomatic or may range from mild to very severe symptoms, including multiorgan dysfunction or fatal pneumonia [ 4 , 5 ].…”

Section: Introductionmentioning

confidence: 99%

Isolated Severe Dysphonia as a Presentation of Post-COVID-19 Syndrome

et al. 2022

View full text Add to dashboard Cite

This is the first study assessing the clinical management of severe, isolated dysphonia during post-COVID-19 syndrome. One hundred and fifty-eight subjects met the inclusion criteria for the post-COVID-19 condition as specified by the WHO. Six patients were diagnosed with isolated severe dysphonia, constituting 3.8% of the initial group. The pre- and post-examination protocol consisted of subjective voice self-assessment and routine laryngological examination, followed by an instrumental examination by means of Laryngovideostroboscopy (LVS) and High-Speed Videolaryngoscopy (HSV). The treatment included short-term systemic steroids in decreasing doses, moisturizing inhalations with hyaluronic acid, and protective agents against Laryngopharyngeal Reflux. The kinematic imaging of the glottis performed by means of HSV before treatment showed deviations in the regularity and symmetry of vocal fold vibrations, absence of mucosal wave, and incomplete glottal closure. Improvement of the structural and functional state of the larynx was observed post-treatment. Kymographic sections and Glottal Width Waveform (GWW) graphs obtained from post-treatment HSV recordings showed improvement in vocal fold vibrations. The decrease in mean Jitter and Shimmer was observed, with the following mean values of 3.16 pre-treatment and 2.97 post-treatment for Jitter and 7.16 pre-treatment and 2.77 post-treatment for Shimmer. The post-treatment self-evaluation of voice showed considerable improvement in vocal function and voice quality in all the examined patients. Severe dysphonia in patients with post-COVID-19 syndrome requires urgent ENT diagnosis using instrumental assessment with the evaluation of laryngeal phonatory function and intensive comprehensive treatment.

show abstract

Increasing Prevalence of Voice Disorders in the USA: Updates in the COVID Era

Naunheim,

DeVore,

Huston

et al. 2024

The Laryngoscope

View full text Add to dashboard Cite

ObjectiveTo estimate the current prevalence of voice disorders among adults in the United States; to determine the association of individual factors with voice disorders.MethodsThe 2022 National Health Interview Survey (NHIS) was analyzed to identify adults reporting voice problems in the past 12 months. Demographics were assessed, as well as the duration, severity, and resolution of the voice problem. The relationship between voice problems, gender, lost workdays, and long COVID was investigated. A comparison to the 2012 NHIS was made to determine changes in voice disorder prevalence.Results29.9 million Americans (95%CI[28.3–31.5]) annually report a voice problem, representing 12.2% of the population (95%CI[11.7–12.8%]). Overall, 26.8% and 13.2% reported the severity of their voice problem as moderate or severe, respectively. Only 5.1% (95%CI[4.3–6.0%]) of respondents sought treatment. Most voice problems were resolved within 1 week (53.0%,95%CI[50.9–55.1%]). Females were more likely than males to report a voice problem (14.4% vs. 10.0%,95%CI[13.7–15.1] and [9.3–10.7], respectively). The 17.6 million Americans with long COVID symptoms were more likely to have voice complaints than those without (21.1% vs. 11.6%,95%CI[18.9–23.5%] and [11.1–12.1%], respectively). Lost workdays were not significantly higher for those with voice disorders compared to those without (17.1 vs. 12.9 days,95%CI[12.0–22.1] and [11.0–14.8], respectively).ConclusionsVoice problems affect approximately 1 in 8 adults in the U.S. annually, demonstrating an alarming increased prevalence since 2012 using the same survey methodology. Relatively few individuals seek care for their voice problem, despite significant self‐reported impact. Further study is required regarding the impact of COVID and changes in voice use patterns on voice disorders.Level of Evidence3 Laryngoscope, 2024

show abstract

Patient reported voice handicap and auditory-perceptual voice assessment outcomes in patients with COVID-19

Cited by 14 publications

References 25 publications

Dysphonia Severity Index and Consensus Auditory-Perceptual Evaluation of Voice Outcomes, and Their Relation in Hospitalized Patients with COVID-19

Dysphonia Severity Index and Consensus Auditory-Perceptual Evaluation of Voice Outcomes, and Their Relation in Hospitalized Patients with COVID-19

Isolated Severe Dysphonia as a Presentation of Post-COVID-19 Syndrome

Increasing Prevalence of Voice Disorders in the USA: Updates in the COVID Era

Contact Info

Product

Resources

About